Canada markets closed

Nurix Therapeutics, Inc. (NRIX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.170.00 (0.00%)
At close: 04:00PM EDT
15.17 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-11-30
2022-11-30
2021-11-30
2020-11-30
2019-11-30
Total Revenue
80,887
76,987
38,627
29,750
17,820
-
Operating Expenses
Research Development
193,337
189,148
184,497
116,434
66,494
-
Selling General and Administrative
44,880
42,902
37,997
31,202
16,309
-
Total Operating Expenses
238,217
232,050
222,494
147,636
82,803
-
Operating Income or Loss
-157,330
-155,063
-183,867
-117,886
-64,983
-
Income Before Tax
-144,643
-143,948
-180,360
-117,063
-63,777
-
Income Tax Expense
-
-
0
131
-20,535
239
Income from Continuing Operations
-144,733
-143,948
-180,360
-117,194
-43,242
-
Net Income
-144,733
-143,948
-180,360
-117,194
-43,242
-
Net Income available to common shareholders
-144,733
-143,948
-180,360
-117,194
-43,242
-
Basic EPS
-2.74
-2.65
-3.71
-2.73
-2.76
-
Diluted EPS
-2.74
-2.65
-3.71
-2.73
-2.76
-
Basic Average Shares
54,152
54,338
48,608
42,895
15,673
-
Diluted Average Shares
54,152
54,338
48,608
42,895
15,673
-